期刊文献+

黄芪对糖尿病颈动脉病变及纤溶酶原激活物抑制物-1表达的影响 被引量:1

下载PDF
导出
摘要 目的探讨黄芪对糖尿病病人颈动脉病变及纤溶酶原激活物抑制物-1(PAI-1)表达的影响。方法Wistar大鼠60只随机分为黄芪组、实验组和对照组,分别于成模后第6周、第10周和第14周每组处死8只,取右颈动脉制病理、电镜切片,并测定病理切片上颈动脉内中膜的厚度。同时测定血浆PAI-1水平。结果实验组和黄芪组大鼠颈动脉内中膜厚度与PAI-1呈显著正相关(r=0.899,P<0.01),实验组大鼠PAI-1浓度显著高于正常对照组和黄芪组,黄芪组大鼠PAI-1浓度显著高于正常对照组,随着病程的进展,呈逐渐增高趋势。结论PAI-1参与了糖尿病颈动脉病变的发生、发展,在糖尿病大血管病变进程中具有重要作用。黄芪可抑制PAI-1的表达,延缓糖尿病颈动脉病变的进展。
出处 《中西医结合心脑血管病杂志》 2008年第7期796-798,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献8

  • 1H - eh WA, Law RE, Insulin signaling in the diabetes [J]. Am J Cacdiol, 1999, 84:21 - 24.
  • 2Sharma KR, Cross J, Darronay O, et al. Demyelinating neuropathy in diabetes mellitus[J]. Arch Neurol,2002,59:758 - 765.
  • 3Brown NJ, Abbas A, Byrne D,et al. Comparative effects of estrogen and angiotensin - converting enzyme inhibition on plas minogen activator inhibitor- 1 in healthy postmenopausal women[J]. Circulation, 2002,105 : 304 - 309.
  • 4岳增辉,严洁,常小荣.高脂血症与血管内皮细胞及其黏附分子的相关研究进展[J].中西医结合心脑血管病杂志,2005,3(2):149-150. 被引量:6
  • 5Sobel BE, Esmon CT, Owen WG,etal. Increased plasminogen activator vinhibitortype 1 in coronary artery atherectomspecimens from type 2 diabetic compared with nondiabetic patients[J]. Circulation,2005,97(22) :2213 - 2221.
  • 6Hosaka Y,Takahashi Y,Ishii H. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thromb in - dependent activation of plasma procarboxypeptidase B [J]. Thromb Haemost,2003,79:371 - 377.
  • 7王宏,孙喜明,程宇甫.黄芪注射液对早期糖尿病肾病纤溶酶原激活物抑制物-1表达的影响[J].中西医结合心脑血管病杂志,2007,5(7):581-582. 被引量:5
  • 8黄进宇,单江,徐耕,傅国胜,高炎.黄芪抑制血管平滑肌细胞增殖及其作用机制[J].中国现代应用药学,2003,20(4):277-279. 被引量:22

二级参考文献35

  • 1史艳玲,邹和群.纤溶酶原激活物抑制剂-1和肾脏疾病[J].国外医学(泌尿系统分册),2005,25(5):708-712. 被引量:3
  • 2陶少平,陈学峰,孙艳,杭宇,周蓓.黄芪注射液对糖尿病肾病患者血转化生长因子-β_1及Ⅳ型胶原水平的影响及其意义[J].中国中西医结合肾病杂志,2006,7(3):156-157. 被引量:42
  • 3英明中,李小鹰,孙存普,吴可,丛建波,汪德清.黄芪总黄酮对大鼠心肌缺血-再灌注自由基的影响[J].中国中药杂志,1996,21(5):304-305. 被引量:53
  • 4FukudaK.通过黄芪、人参和黄芩水提物的处理增加血管平滑肌细胞中NO合酶和环磷鸟苷[J].和汉医学杂志,1995,12(1):38-38.
  • 5Laird JR,Carter AJ, Kufs WM, et al. Inhibition of Neointimal proliferation with low-dose irriadiation from a b-particle -emit-ting stent[J]. Circulation, 1996.93: 529.
  • 6Tarry WC, Makhoul RG. L-arginine improve endothelium-de-pendent vasorelexaation and reduces intimal hyperplasia after angioplasty[J], Arterioscler Thromb, 1994,14 : 938.
  • 7Gro J, Milhoa K, Tuan R, et al. Benificial effects of SPM-5185, a cysteine-containing nitric oxide donor,in rat carotid artery intimal injury[J]. Circ Res, 1994,4:232.
  • 8Toyoshima H, Hunter T. p27, a novel inhibitor of Gi cyclin-Cdk protein kinase activity, is related to p21[J]. Cell, 1994,78:67.
  • 9Ihling C, Menzel G, Wellens, E et al. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue[J]. Arterioscler Thromb Vasc Biol, 1997, 17:2218.
  • 10Sato J, Nair K, Hiddinga J, et al. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of P27 and P21 and apoptosis[J]. Carc Res, 2000, 47:697.

共引文献30

同被引文献17

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部